With Investors’ Eyes on Biotechs, Biotechs Must Be Transparent
If recent pharmaceutical mergers and acquisitions are any indication, 2019 is poised to marked by industry deal-making. Earlier this month, the J.P. Morgan Healthcare Conference
If recent pharmaceutical mergers and acquisitions are any indication, 2019 is poised to marked by industry deal-making. Earlier this month, the J.P. Morgan Healthcare Conference
This article originally appeared in Applied Clinical Trials. With 2018 not far behind us, we turn our attention to the coming year. On a daily basis,
DECEMBER 19, 2018 by Shelley Webb Having been both an R.N. and a patient, I have experienced both sides of the lack of transparency in
DECEMBER 12, 2018 by Kathy Birkett How many people do you know who have participated in a clinical trial? A clinical trial or research study
NOVEMBER 28, 2018 Marketing efforts designed for clinical trial recruitment are a combination of science and art. Healthcare professionals are engaged in an increasingly competitive
OCTOBER 15, 2018 Many clinical trial sponsors are so focused on initial submission and updates of their studies on government registries in an accurate and
OCTOBER 8, 2018 In this TrialScope Q&A, Chief Marketing Officer Naor Chazan discusses the current state of clinical trial websites with two user experience experts. See
SEPTEMBER 13, 2018 The EU Trials Tracker, produced by the EBM DataLab at the University of Oxford, is now live. In light of this and an accompanying
SEPTEMBER 2, 2018 TrialScope recently completed a brief phone survey with a group of trial sponsors that have previously made public commitments to plain (lay)
Copyright © 2022 Pharma Intelligence UK Limited
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is Suite 1, 3rd Floor, 11 – 12 St. James’s Square, London, England, SW1Y 4LB. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group